Overall, this guidance could help many migraine sufferers gain better control over their symptoms—and with fewer disruptions ...

5-hydroxytriptamine is a key mediator in the pathogenesis of migraine and thus 5-HT 1-receptor agonists are the principal drugs for acute migraine therapy. There are three classes of drugs for ...

There are now a number of additional migraine treatments available, including those that don’t seem to have the same risk of MOH. Hormone therapies are at the top of the list of medications that ...

This article uses the term “Maxalt” to describe both forms of the drug. Migraine is a neurological (brain and nervous system) condition that causes recurrent episodes of moderate to severe ...

The global Migraine Drugs Market is valued at $6.37 billion in 2024 and is projected to reach a value of $21.59 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of 11.75% between 2025 ...

In a clinical guideline issued by the American College of Physicians (ACP) and published online March 18 in the ...

For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study. Researchers found the drug zonisamide, which has been used to treat seizures ...

“Although using a triptan alone is an effective treatment option, ACP found evidence that supports better migraine-related outcomes with the use of a triptan plus a nonsteroidal anti-inflammatory drug ...

Researchers found the drug zonisamide, which has been used to treat seizures, may reduce migraine days in this age group. This study does not prove that zonisamide reduces migraine days ...